Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
Article
Machiraju, Devayani, Schäfer, Sarah, Beckhove, Philip, Roth, Jasmin, Schulz, Carsten and Hassel, Jessica C. (2023) Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma. Frontiers in Medicine 10.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Frontiers in Medicine | ||||
| Publisher | FRONTIERS MEDIA SA | ||||
| Place of Publication | LAUSANNE | ||||
| Volume | 10 | ||||
| Date | 2023 | ||||
| Date of publication | 18 Mar 2025 10:03 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | MEMORY T-CELLS; CHOICE CHEMOTHERAPY; CANCER; ADOLESCENT; IPILIMUMAB; NIVOLUMAB; SURVIVAL; EFFICACY; CHILDREN; melanoma; young adults; memory T cells; soluble immune checkpoint proteins; age; immune checkpoint inhibitors (ICI) | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 75641 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric